Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis
Open Access
- 30 November 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Abstract
Aim: The Gustave Roussy Immune Score (GRIm-Score) was originally designed to select cancer patients for immunotherapy, and later was reported to be a novel prognostic scoring system in lung cancer and esophageal cancer. This study was aimed to determine the prognostic role and predictive performance of GRIm-Score in colorectal cancer (CRC) CRC patients. Methods: We conducted a single-institution study of 1,579 adult CRC patients receiving surgical removal, and those patients were divided into low GRIm-Score group (scores 0, 1) and high GRIm-Score group (scores 2, 3). Propensity score matching (PSM) was executed to balance the potential confounding factors between the two groups. Survival and time-dependent receiver operating characteristic (Td-ROC) analyses were applied to depict the prognostic role and predictive significance of GRIm-Score in CRC patients. Results: There were 200 cases CRC patients in high GRIm-Score group and 1,379 cases in low GRIm-Score group. CRC patients with high GRIm-Score correspond with higher level of CEA, CA125, and inflammatory indexes, such as NLR, PLR, SII, PNI, and ALRI. Correlation analysis exhibited that GRIm-Score correlated well with the established inflammatory indexes. Survival analysis revealed that CRC patients in high GRIm-Score group showed worse overall survival (OS, P Conclusion: GRIm-Score, a novel inflammatory and nutritional risk scoring system, is a potent prognostic index in CRC patients receiving surgical removal. GRIm-Score can be used as an effective and simplified risk stratification tool for postoperative survival prediction of CRC patients.Keywords
This publication has 30 references indexed in Scilit:
- Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patientsBMC Cancer, 2018
- Colorectal cancer screening: is earlier better?The Lancet Gastroenterology & Hepatology, 2018
- Statistical primer: propensity score matching and its alternatives†European Journal of Cardio-Thoracic Surgery, 2018
- Pretreatment Inflammatory Indexes as Prognostic Predictors for Survival in Colorectal Cancer Patients Receiving Neoadjuvant ChemoradiotherapyScientific Reports, 2018
- Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)European Journal of Cancer, 2017
- Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based studyBritish Journal of Cancer, 2017
- Colorectal cancer—global burden, trends, and geographical variationsJournal of Surgical Oncology, 2017
- Propensity score matching and complex surveysStatistical Methods in Medical Research, 2016
- The ModifiedGlasgow Prognostic Score and Survival in Colorectal Cancer: A Pooled Analysis of the LiteratureReviews on Recent Clinical Trials, 2015
- Serum albumin and colorectal cancer riskEuropean Journal of Clinical Nutrition, 2000